Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 5.46BPL Ltd, operating in the consumer durables sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by a healthy equity position and solid margins. Revenue and asset growth are positive, indicating market expansion. However, liquidity is a concern, with low current and cash ratios. Efficiency is also mixed, with good inventory management but challenges in asset utilization and receivable collection. While interest coverage is adequate, the absence of dividend coverage is a notable weakness. Overall, BPL showcases potential with its growth and profitability, but needs to address liquidity and efficiency to ensure sustainable financial health. Recent capital expenditure may be a cause for concern.
Health Score : 5.46BPL Ltd, operating in the consumer durables sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by a healthy equity position and solid margins. Revenue and asset growth are positive, indicating market expansion. However, liquidity is a concern, with low current and cash ratios. Efficiency is also mixed, with good inventory management but challenges in asset utilization and receivable collection. While interest coverage is adequate, the absence of dividend coverage is a notable weakness. Overall, BPL showcases potential with its growth and profitability, but needs to address liquidity and efficiency to ensure sustainable financial health. Recent capital expenditure may be a cause for concern.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-16.67
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
-28.58
P/B RATIO
1.02
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
3.16
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-111.37
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹50.02 as on Sep 1, 2026.
Growth Score : 6.00The company demonstrates strong revenue and asset growth, along with a significant increase in operating profit. However, earnings per share and net income growth are negative, indicating potential issues with profitability despite revenue gains. Overall, the company is expanding its operations, but profitability needs to catch up with revenue growth. The company has potential to grow, but profitability is a major concern.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 36.52 | 27.21 | 17.96 | -0.31 |
| Operating Profit Growth Rate | 4446.15 | 142.3 | -12.57 | -138.5 |
| Earnings Per Share (EPS) Growth | -61.13 | 168.93 | -98.19 | -3600 |
| Asset Growth Rate | 11.73 | 2.86 | -0.56 | 16.44 |
| Net Income Growth Rate | -60.93 | 165.02 | -99.25 | -8650 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 2 | SMS Lifesciences India Ltd | 6.59 | 22.25 | Undervalued | 45.00 | 58.80 | 19.00 |
| 3 | Infinium Pharmachem Ltd | 6.42 | 33.97 | Neutral | 22.00 | 6.43 | 14.00 |
| 4 | Aarey Drugs & Pharmaceuticals Ltd | 5.73 | 60.35 | Neutral | 7.00 | 1.40 | 4.00 |
| 5 | Albert David Ltd | 5.63 | -333.98 | Neutral | 5.00 | -2.62 | -1.00 |
| 6 | BPL Ltd | 5.46 | -28.58 | Neutral | -4.82 | -1.69 | -8.55 |
| 7 | Zim Laboratories Ltd | 5.41 | 108.20 | Neutral | 30.00 | 1.11 | 6.00 |
| 8 | Quest Laboratories Ltd | 5.27 | 9.34 | Neutral | 18.00 | 9.16 | 15.00 |
| 9 | Sotac Pharmaceuticals Ltd | 5.27 | 17.25 | Neutral | 18.00 | 4.45 | 6.00 |
| 10 | Lyka Labs Ltd | 4.77 | -26.63 | Neutral | -4.00 | -8.93 | -10.00 |
| 11 | Krebs Biochemicals & Industries Ltd | 4.16 | -4.36 | Highly Undervalued | -4.00 | -7.85 | -4.00 |
| 12 | Nectar Lifescience Ltd | 3.83 | -0.80 | Neutral | -59.00 | -2.95 | -293.00 |
| 13 | PANCHSHEEL | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
BPL Ltd is an Indian consumer electronics company, once a market leader, now operating on a significantly reduced scale. It is primarily involved in brand licensing agreements and limited trading activities across various consumer electronics and home appliances. The company maintains its legacy brand presence while navigating a highly competitive market.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. BPL Ltd's P/E ratio (TTM) is -16.67, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. BPL Ltd's P/B ratio is 1.02, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. BPL Ltd's P/S ratio is 3.16, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. BPL Ltd's PEG ratio is N/A (due to negative earnings).
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. BPL Ltd's EV/EBITDA ratio is -111.37.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. BPL Ltd's ROE is -3.55%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. BPL Ltd's ROA is -0.68%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. BPL Ltd's ROCE is -1.22%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. BPL Ltd's operating margin is -6.17%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. BPL Ltd's net margin is -10.94%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. BPL Ltd's current ratio is 0.59.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. BPL Ltd's debt-to-equity ratio is 0.39.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. BPL Ltd's interest coverage ratio is -3.80.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. BPL Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. BPL Ltd's EPS is -3600.
(Source line: "Ratios as of 25 Sept 2026, based on last traded price of ₹50.02. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1963 (as British Physical Laboratories India Private Limited)
Headquarters: Bengaluru, Karnataka
Core Offerings: Brand licensing, manufacturing of select consumer electronics, trading of home appliances, healthcare products
Stock Listing: NSE (BPL), BSE (500074)
Promoter: Nambiar Group / T.P.G. Nambiar
BPL Ltd was incorporated in 1963 as British Physical Laboratories India Private Limited, initially focusing on precision electronic instruments. It rose to prominence in the 1980s and 1990s as a leading Indian consumer electronics brand, especially known for its televisions, VCRs, and audio systems. Post-liberalization, it faced intense competition from multinational companies, leading to a significant decline in its market share and financial performance. Today, the company operates on a much smaller scale, often through brand licensing arrangements and limited manufacturing and trading activities.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Consumer Electronics & Appliances | Approx. 100% | N/A (often negative) |
Mr. Ajit G. Nambiar (Chairman & Managing Director): Son of the founder T.P.G. Nambiar, he has been instrumental in leading the company through its various phases, aiming to revive the brand's legacy.
No major subsidiaries reported.
No major recent corporate actions on record.
The BPL Ltd share price today is ₹50.02 on NSE (BPL), as of 26 Sept 2026.
As of 25 Sept 2026, BPL Ltd share price is ₹50.02, with previous close ₹50.02. Today's range is ₹50.02 to ₹50.02. The 52-week range is ₹37.61 to ₹72.99.
As of today, BPL Ltd's market cap is ₹247.1 crore (Small Cap).
BPL Ltd's current P/E ratio is -16.67, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 60.
BPL Ltd's current P/B ratio is 1.02.
BPL Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
BPL Ltd's EPS (TTM) is ₹-3600.
BPL Ltd is an Indian consumer electronics company, once a market leader, now operating on a significantly reduced scale. It is primarily involved in brand licensing agreements and limited trading activities across various consumer electronics and home appliances. The company maintains its legacy brand presence while navigating a highly competitive market.
BPL Ltd is promoted by Nambiar Group / T.P.G. Nambiar, holding 63.13% as of 25 Sept 2026.
BPL Ltd is listed on NSE (BPL) and BSE (500074). Its next quarterly results are expected on November 2024 (for Q2 FY25).
Cash Earnings Per Share (Cash EPS)
Capital Efficiency & Returns